Skip to main content
. 2013 Jun 10;14:58. doi: 10.1186/1471-2202-14-58

Figure 6.

Figure 6

Neurological deficit scores (A) and infarct volume percentages (B) following transient MCAO over seven days. The neurobehavioral outcome in the HPX-administration (1.86 mg/ml) group was far superior as compared with the vehicle group. In addition, the brain infarct volumes were significantly reduced. ## P<0.01 in comparison with the vehicle group. (n=8 for each group).